Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition-Reference-Cited by-同舟云学术

Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition

Published:2021-01-01 Issue:1 Volume:12 Page:914-926
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Alanazi Saleh A.¹²,Harisa Gamaleldin I.¹³⁴,Badran Mohamed M.³⁵,Alanazi Fars K.¹,Elzayat Ehab¹³,Alomrani Abdullah H.³⁶,Al Meanazel Osaid T.¹⁷,Al Meanazel Ahmed T.⁸

Affiliation:

1. Kayyali Chair for Pharmaceutical Industries, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

2. Pharmaceutical Care Services, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia

3. Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

4. Department of Biochemistry, College of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt

5. Department of Pharmaceutics, College of Pharmacy, Al-Azhar University, Nasr City Cairo, Egypt

6. Nanobiotechnology Unit, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

7. Michael Sayegh Faculty of Pharmacy, Aqaba University of Technology, Aqaba, Jordan

8. Prince Naif for the Health Research Center, King Saud University, Riyadh, Saudi Arabia

Funder

Vice Research Chairs at King Saud University, Saudi Arabia for funding this work through Kayyali Chair for Pharmaceutical Industry

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1896202

Reference43 articles.

1. Liver Stem Cells: Implications for Hepatocarcinogenesis

2. Chemotherapy for hepatocellular carcinoma: The present and the future

3. Challenge and Hope in Radiotherapy of Hepatocellular Carcinoma

4. Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma

5. Decreased PCSK9 expression in human hepatocellular carcinoma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan-enclosed SLN improved SV-induced hepatocellular cell carcinoma death by modulation of IQGAP gene expression, JNK, and HDAC activities;Molecular Biology Reports;2024-07-18

2. The Chimera of TPGS and Nanoscale Lipid Carriers as Lymphatic Drug Delivery Vehicles to Fight Metastatic Cancers;Current Drug Delivery;2024-05

3. The application strategy of liposomes in organ targeting therapy;WIREs Nanomedicine and Nanobiotechnology;2024-03

4. Tyloxapol and nanoliposomes induce selective delivery of 5‐fluorouracil into hepatic tissues via VLDL/LDL‐mediated pathway;European Journal of Lipid Science and Technology;2023-11-03

5. TPGS decorated NLC shift gefitinib from portal absorption into lymphatic delivery: Intracellular trafficking, biodistribution and bioavailability studies;Colloids and Surfaces B: Biointerfaces;2023-03